Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions
The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has elicited a global health crisis of catastrophic proportions. With only a few vaccines approved for early or limited use, there is a critical need for effective antiviral strategies. In this study, we report a unique antiviral pla...
Main Authors: | Chatterjee, Pranam (Author), Ponnapati, Manvitha (Author), Kramme, Christian (Author), Plesa, Alexandru M. (Author), Church, George M. (Author), Jacobson, Joseph (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Center for Bits and Atoms (Contributor), Massachusetts Institute of Technology. Media Laboratory (Contributor) |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC,
2020-11-30T19:51:09Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions
by: Pranam Chatterjee, et al.
Published: (2020-11-01) -
Peptide targets to SARS-CoV-2
by: Santi M Mandal
Published: (2020-01-01) -
In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01) -
Minimal PAM specificity of a highly similar SpCas9 ortholog
by: Chatterjee, Pranam, et al.
Published: (2020) -
Intracellular Delivery of Proteins via Fusion Peptides in Intact Plants.
by: Kiaw Kiaw Ng, et al.
Published: (2016-01-01)